Homozygous familial hypercholesterolemia: Current perspectives on diagnosis and treatment (2012)
- Authors:
- USP affiliated author: SANTOS FILHO, RAUL DIAS DOS - FM
- School: FM
- DOI: 10.1016/j.atherosclerosis.2012.02.019
- Subjects: DOENÇAS HEREDITÁRIAS; LIPOPROTEÍNAS; HIPERCOLESTEROLEMIA (DIAGNÓSTICO;TERAPIA); APOLIPOPROTEÍNAS
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Atherosclerosis
- ISSN: 0021-9150
- Volume/Número/Paginação/Ano: v. 223, n. 2, p. 262-268, 2012
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
RAAL, Frederick J.; SANTOS, Raul D. Homozygous familial hypercholesterolemia: Current perspectives on diagnosis and treatment. Atherosclerosis, Amsterdam, v. 223, n. 2, p. 262-268, 2012. Disponível em: < http://dx.doi.org/10.1016/j.atherosclerosis.2012.02.019 > DOI: 10.1016/j.atherosclerosis.2012.02.019. -
APA
Raal, F. J., & Santos, R. D. (2012). Homozygous familial hypercholesterolemia: Current perspectives on diagnosis and treatment. Atherosclerosis, 223( 2), 262-268. doi:10.1016/j.atherosclerosis.2012.02.019 -
NLM
Raal FJ, Santos RD. Homozygous familial hypercholesterolemia: Current perspectives on diagnosis and treatment [Internet]. Atherosclerosis. 2012 ; 223( 2): 262-268.Available from: http://dx.doi.org/10.1016/j.atherosclerosis.2012.02.019 -
Vancouver
Raal FJ, Santos RD. Homozygous familial hypercholesterolemia: Current perspectives on diagnosis and treatment [Internet]. Atherosclerosis. 2012 ; 223( 2): 262-268.Available from: http://dx.doi.org/10.1016/j.atherosclerosis.2012.02.019 - Is there relationship between epicardial fat and cardiovascular parameters in incident kidney transplant patients?: a post-hoc analysis
- Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS)
- Prevalência de síndrome metabólica e escore de risco de Framingham em homens vegetarianos e onívoros aparentemente saudáveis
- Case report [Editorial]: the efficacy and safety of lomitapide in a homozygous familial hypercholesterolemic child
- Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia: results from the SPIRE randomized trials of bococizumab
- The selective peroxisome proliferator-activated receptor alpha modulator (SPPARM) paradigm: conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation
- Low-density lipoprotein cholesterol goal achievement in patients with familial hypercholesterolemia in countries outside Western Europe: the International ChoLesterol management Practice Study
- Non-high-density lipoprotein cholesterol target achievement in patients on lipid-lowering drugs and stratified by triglycerid levels in the Arabian Gulf
- Blood pressure is associated with the presence and severity of nonalcoholic fatty liver disease across the spectrum of cardiometabolic risk
- Predicting Cardiovascular Events in Familial Hypercholesterolemia
Informações sobre o DOI: 10.1016/j.atherosclerosis.2012.02.019 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
